TelyRx Holdings Inc. is making waves on the TSX with a notable 6.12% increase in its stock price today, closing at CA$2.60.
In an impressive turn of events, TelyRx Holdings Inc. (TELY.TO) has seen its stock soar by 6.12% in the last trading session. This surge comes on the back of significant company milestones and an upcoming investor conference that has captured the attention of the market.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$66.45M
52W high
$4.25
52W low
$2.00
1W change
+2.94%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 144.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+144.9% Upside
Current Price
C$2.45
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
83.1%
Annualized
90-Day Vol
92.4%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$2.05
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$2.31 | C$1.73 โ C$3.07 |
| 60 trading days | C$2.18 | C$1.45 โ C$3.26 |
| 90 trading days | C$2.05 | C$1.25 โ C$3.37 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: For Canadian investors looking for growth opportunities in the healthcare sector, TelyRx's recent performance and strategic initiatives may present a compelling case for further evaluation.
TelyRx Holdings Inc. stock rises 6.12% today
The stock's closing price of CA$2.60 reflects growing investor optimism about TelyRx's future prospects.
Bull case
TelyRx recently achieved a major milestone by filling one million prescriptions, which highlights its growing presence in the healthcare sector. This accomplishment not only demonstrates the company's operational strength but also boosts investor confidence as it expands its services. Additionally, TelyRx will present at the Global Technology Virtual Investor Conference, which could further attract interest in its innovative healthcare solutions.
Bear case
Despite today's positive movement, TelyRx faces challenges with its negative profit margin and the risks associated with the healthcare sector. These factors could hinder sustained growth and profitability, so investors should remain cautious.
Advertisement
